Kruxade (Amoxicillin, Clavulanic Acid)

Kruxade is an oral antibacterial that targets a broad range of bacterial pathogens in common infections.

• Acute sinusitis: reduces symptoms and clears the infection.
• Community‑acquired pneumonia: provides effective bacterial eradication.
• Acute otitis media: relieves ear pain and eliminates causative organisms.
• Uncomplicated urinary tract infections: resolves urinary symptoms and bacterial load.
• Skin and soft‑tissue infections: treats cellulitis and related bacterial skin conditions.

• Amoxicillin inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, while clavulanic acid blocks beta‑lactamase enzymes that would otherwise degrade amoxicillin. This combination extends the antibacterial spectrum to include beta‑lactamase‑producing organisms, allowing effective eradication of susceptible bacteria.

Adverse reactions may occur with any antibiotic and should be monitored.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: increased bowel movements, sometimes loose.
• Rash: skin redness or itching.
• Vomiting: occasional emesis.
• Abdominal pain: cramping or discomfort.
• Headache: transient mild headache.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction requiring emergency care.
• Clostridioides difficile‑associated diarrhea: severe colitis.
• Liver enzyme elevation: signs of hepatic stress.
• Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.
• Neutropenia: reduced white blood cell count.
• Hemolytic anemia: destruction of red blood cells.

Use Kruxade only under medical supervision and consider the following precautions.

• Allergy assessment: confirm no known penicillin or beta‑lactamase inhibitor allergy.
• Renal function: adjust dose in patients with impaired kidney function.
• Hepatic monitoring: observe liver function during prolonged therapy.
• Pregnancy safety: use only if clearly needed; data are limited.
• Concomitant beta‑lactam allergy: avoid in patients with documented hypersensitivity.
• Store at ambient temperature: keep in the original pack, protect from moisture.

Kruxade may interact with other medicines; review patient medication lists.

Major Interactions (Avoid)

• Probenecid: increases amoxicillin plasma levels, risking toxicity.
• Warfarin: may enhance anticoagulant effect, increasing bleeding risk.
• Methotrexate: can raise methotrexate concentrations, leading to toxicity.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: may reduce efficacy, consider backup contraception.
• Allopurinol: increased risk of rash.
• Diuretics (e.g., furosemide): may cause potassium loss.
• Antacids containing aluminum or magnesium: can reduce amoxicillin absorption.